ILBS
Delhi, 110070, India
NCT Number: NCT06909175
Liver transplantation is usually associated with hemodynamic instability. TEE allows for a real time monitoring of cardiac structures and has become a standard of care for liver transplant patients. Society of cardiovascular anaesthesia and American society of anaesthesiologists recommends use of TEE in non-cardiac surgery patients with hemodynamic instability. Also, society for advancement of transplant anaesthesia (SATA) has suggested that TEE usage in cases of liver transplant is safe, effective and improves outcomes. TEE can also provide vital information relating to non-cardiac structures including liver, spleen, kidneys, portal vein, hepatic vein and other major vessels. As of now standard protocol is to do the transabdominal doppler for the assessment of portal vein after the liver graft implantation. Hence, the aim of our study is to compare the transesophageal echocardiography and transabdominal Doppler for assessing portal vein in living donor liver transplantation.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Delhi, 110070, India
Data from all patients who underwent live donor liver transplant surgery at Institute of Liver and Biliary Sciences, New Delhi and in whom TEE probe was inserted will be collected and analysed.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Portal vein velocities were measured using TEE and intraoperative doppler in patients undergoing living donor liver transplantation
Time frame: intraoperative period
Time frame: intraoperative period
Institute of Liver and Biliary Sciences, India
Other
Comparing Transesophageal Echocardiography and Trans Abdominal Doppler for Portal Vein Assessment in Living Donor Liver Transplantation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06642740
Blood Platelet Disorders, Chronic Liver Disease
Beijing, Beijing Municipality, China
View Trial DetailsNCT05118308
Chronic Liver Disease, Cirrhosis
Montreal, Quebec, Canada
View Trial DetailsNCT05532124
Chronic Liver Disease
Daegu, South Korea
View Trial DetailsNCT05044663
Chronic Liver Disease
New Delhi, National Capital Territory of Delhi, India
View Trial Details